Literature DB >> 11096342

Cytoplasmic beta-catenin accumulation as a predictor of hematogenous metastasis in human colorectal cancer.

K Maruyama1, A Ochiai, S Akimoto, S Nakamura, S Baba, Y Moriya, S Hirohashi.   

Abstract

The membranous, cytoplasmic and nuclear levels of beta-catenin were evaluated immunohistochemically in archival tissue specimens from 96 Japanese patients with primary colorectal carcinoma who had undergone surgery. The relationships between beta-catenin and clinicopathological variables were analyzed statistically. Reduced beta-catenin immunoreactivity in the cell membranes of cancer cells was found in 70% of the tumors, and cytoplasmic and nuclear accumulation of beta-catenin were found in 68 and 66% of tumors, respectively. Significant correlations between cytoplasmic beta-catenin accumulation and the depth of invasion, venous invasion and focal dedifferentiation were observed. Cytoplasmic beta-catenin accumulation was also found to be a useful predictor of hematogenous metastasis (hazard ratio = 8.94, p = 0.054), though neither a reduced cell membrane level nor nuclear accumulation of beta-catenin correlated with metastasis. Copyright 2000 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11096342     DOI: 10.1159/000012187

Source DB:  PubMed          Journal:  Oncology        ISSN: 0030-2414            Impact factor:   2.935


  41 in total

1.  The impact of expressions of CD97 and its ligand CD55 at the invasion front on prognosis of rectal adenocarcinoma.

Authors:  Shao-Liang Han; Chang Xu; Xiu-Ling Wu; Jun-Lin Li; Zhi Liu; Qi-Qiang Zeng
Journal:  Int J Colorectal Dis       Date:  2010-03-26       Impact factor: 2.571

2.  Survey of molecular profiling during human colon cancer development and progression by immunohistochemical staining on tissue microarray.

Authors:  Wei-Chang Chen; Mao-Song Lin; Bao-Feng Zhang; Jing Fang; Qiong Zhou; Ying Hu; Heng-Jun Gao
Journal:  World J Gastroenterol       Date:  2007-02-07       Impact factor: 5.742

3.  EBV-encoded LMP1 increases nuclear β-catenin accumulation and its transcriptional activity in nasopharyngeal carcinoma.

Authors:  Shuyuan You; Fenfen Zhang; Fengjiao Meng; Hui Li; Qiuyu Liu; Yingjie Liang; Yu Dong; Wancai Yang; Anjia Han
Journal:  Tumour Biol       Date:  2011-02-19

4.  Expression and regulation of CD97 in colorectal carcinoma cell lines and tumor tissues.

Authors:  Matthias Steinert; Manja Wobus; Carsten Boltze; Alexander Schütz; Mandy Wahlbuhl; Jörg Hamann; Gabriela Aust
Journal:  Am J Pathol       Date:  2002-11       Impact factor: 4.307

5.  Relationship between osteopontin and β-catenin immunohistochemical expression and prognostic parameters of colorectal carcinoma.

Authors:  Nermeen S Youssef; Wesam M Osman
Journal:  Int J Clin Exp Pathol       Date:  2015-02-01

6.  E-cadherin and β-catenin expression in sebaceous eyelid adenocarcinomas.

Authors:  Liang Li; Zhe Zhang; Bin Li; Fei Gao; Liaoqing Li; Jost B Jonas
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2011-07-08       Impact factor: 3.117

7.  Role of CD97(stalk) and CD55 as molecular markers for prognosis and therapy of gastric carcinoma patients.

Authors:  Yong Liu; Li Chen; Shu-You Peng; Zhou-Xun Chen; C Hoang-Vu
Journal:  J Zhejiang Univ Sci B       Date:  2005-09       Impact factor: 3.066

Review 8.  Wnts and the hallmarks of cancer.

Authors:  Zheng Zhong; Jia Yu; David M Virshup; Babita Madan
Journal:  Cancer Metastasis Rev       Date:  2020-09       Impact factor: 9.264

9.  Immunohistochemical study of β-catenin and functionally related molecular markers in tongue squamous cell carcinoma and its correlation with cellular proliferation.

Authors:  Xia Yun; Lihong Wang; Lei Cao; Norihiko Okada; Yoshio Miki
Journal:  Oncol Lett       Date:  2010-05-01       Impact factor: 2.967

10.  Expression and clinical significance of SALL4 and β-catenin in colorectal cancer.

Authors:  Liliang Hao; Yan Zhao; Zhen Wang; Hongzhuan Yin; Xin Zhang; Tao He; Shanshan Song; Shaolong Sun; Baosheng Wang; Zhijie Li; Qi Su
Journal:  J Mol Histol       Date:  2016-01-16       Impact factor: 2.611

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.